Table 6 Cumulative antibiogram based on the most frequent isolates in PNA and UTI cases

Beta-lactam antibacterials: penicillins with extended spectrum, beta-lactamase resistant penicillins, combinations of penicillins incl. beta-lactamase inhibitors

 Piperacillin

n/a

87%

0%

n/a

47%

n/a

7%

 Ampicillin

n/a

87%

n/a

100%

47%

n/a

n/a

 Ampicillin-sulbactam

n/a

87%

72%

100%

83%

n/a

43%

 Amoxicillin-clavulanic acid

n/a

87%

44%

100%

83%

n/a

57%

 Piperacillin-tazobactam

n/a

87%

50%

100%

92%

n/a

57%

Other beta-lactam antibacterials: second/third generation cephalosporins, carbapenems

 Imipenem

12%

87%

94%

0%

100%

0,0

100%

 Meropenem

14%

87%

94%

n/a

100%

7%

100%

 Cefuroxime

n/a

87%

6%

n/a

86%

n/a

50%

 Cefotaxime

n/a

87%

61%

n/a

86%

n/a

57%

 Ceftazidime

n/a

87%

n/a

n/a

86%

n/a

n/a

 Cefepime

n/a

87%

61%

n/a

92%

n/a

64%

 Ceftazidime-avibactam

n/a

87%

100%

n/a

n/a

n/a

100%

Aminoglycoside antibacterials

 Amikacin

26%

96%

83%

n/a

92%

21%

86%

 Gentamicin

55%

100%

78%

20%

50%

71%

71%

 Tobramycin

31%

96%

67%

n/a

86%

14%

57%

Quinolone antibacterials

 Ciprofloxacin

2%

0%

61%

n/a

78%

0%

57%

 Levofloxacin

2%

0%

61%

n/a

78%

0%

50%

 Moxifloxacin

n/a

80%

n/a

n/a

n/a

n/a

n/a

Other antibacterials

 Colistin

95%

n/a

n/a

n/a

n/a

93%

n/a

 Trimethoprim-sulfamethoxazole

19%

100%

78%

n/a

78%

29%

57%

 Fosfomycin

n/a

n/a

n/a

n/a

100%

n/a

n/a

 Nitrofurantoin

n/a

n/a

n/a

100%

89%

n/a

n/a

 Nitroxoline

n/a

n/a

n/a

n/a

100%

n/a

n/a

 Rifampicin

n/a

100%

n/a

n/a

n/a

n/a

n/a

 Teicoplanin

n/a

100%

n/a

100%

n/a

n/a

n/a

 Vancomycin

n/a

100%

n/a

100%

n/a

n/a

n/a

 Tetracycline

n/a

96%

n/a

n/a

n/a

n/a

n/a

 Tigecycline

n/a

100%

n/a

n/a

n/a

n/a

n/a

 Clindamycin

n/a

76%

n/a

n/a

n/a

n/a

n/a

 Erythromycin

n/a

76%

n/a

n/a

n/a

n/a

n/a

 Linezolid

n/a

100%

n/a

100%

n/a

n/a

n/a